1 min read

Achieve Regulatory Excellence and Accelerate Your Clinical Trials with Veristat

Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global regulatory submissions, achieving early and successful outcomes.

In one case, a clinical-stage biopharmaceutical company approached us for an IND submission for an antibody therapy targeting cancer. Our team adapted to staffing challenges on the sponsor’s end, executing a flawless submission that led to FDA clearance ahead of schedule.

In another instance, we supported a biopharmaceutical company with multiregional submissions for a novel therapy targeting a rare genetic metabolic disease. By optimizing resources, Veristat experts helped secure orphan drug designations and priority reviews with both EMA and FDA.

Additionally, a small biotech developing a novel autoimmune therapy sought our expertise for a three-tiered marketing submission to FDA, MHRA, and EMA. Despite competitive pressures, our strategic approach ensured timely submissions and ongoing support.

Discover how Veristat can help you achieve regulatory success by downloading our case study today.

DOWNLOAD NOW

 

2 min read

Triangle Perspective on AI, ML, & the Future of Drug Development

Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...

2 min read

2024 ASCO Annual Meeting

Meet the Veristat team at ASCO,  May 31st to June 4th in Chicago  

The Science-First CRO™ and Consultancy Ready to...